ClinicalTrials.gg
CompletedNCT04536116LIVEUpdated Jan 30, 2025

Virtual Reality As Anxiety Management Tool for Preparing Children for MR Exam

An interventional study of Virtual Reality headset in Claustrophobia, sponsored by Central Hospital, Nancy, France. Completed at 1 site in France. Open to participants aged 6 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-01-30.

Sponsored by Central Hospital, Nancy, France · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
6 Years to 12 Years
Sex
All
01

Study summary

The access to MRI examination is limited due to the duration of the acquisitions, the noise and the narrow patient space of the device. A child can, therefore, be anxious, less cooperative and move more during the acquisition, affecting the quality of the examination and the medical diagnosis. General anesthesia or sedation, may be considered to obtain diagnostic quality examinations. Our hypothesis is that a scenario as close as possible to reality to prepare children before the MR exam could reduce their anxiety, improve the quality of the exams and reduce its duration.

The purpose of this study is to evaluate the effect of virtual reality on MRI exam preparation to reduce the anxiety of children (aged from 6 to 12 years) who are referred to their first MRI exam, as compared to the current practice.

02

Conditions studied

  • Claustrophobia
03

In context

Lead sponsor

Central Hospital, Nancy, France is the lead sponsor of 798 studies on the registry; 186 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Child from 6 to 12 years old,
  • Child who will have an MRI for the first time,
  • Outpatient child,
  • Child dependent on a parent affiliated to or beneficiary of a social security scheme,
  • Child who has received age-appropriate information on the organization of the research,
  • Child whose parents (or the only parent present with parental authority) have been fully informed about the organization of the research and have signed .

Exclusion criteria

Exclusion Criteria:

  • Conditions that not allow the realization of a virtual MRI sceanrio or not allow to respond the scales (epilepsy, mental disorders, language, ...),
  • Child with a to performing an MRI,
  • Child who has benefited from another MRI simulation system before ("IRM en Jeu" for instance)
  • Child's opposition to participate.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
44 participants (actual)

Study arms

  • Experimental
    MRI simulation

    MRI simulation with a Virtual Reality headset

    Device: Virtual Reality headset

  • No intervention
    Standard medical care

    Standard medical care

Interventions

  • DeviceVirtual Reality headset

    MRI simulation with a Virtual Reality headset

06

What researchers measure

Primary outcomes

  1. Anxiety

    Anxiety measurement before and after MRI by Visual Analogue Scale between 0 and 10

    Time frame: 2 hours

07

Study locations

1 site
  • CHRU de Nancy
    Vandoeuvre les nancy, 54500, France
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Nov 2020 to primary completion in Oct 2023, 35 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 5, 2020
First posted
Sep 2, 2020
StartActual
Nov 4, 2020
Primary completionActual
Oct 18, 2023
CompletionActual
Oct 18, 2023
Last update
Jan 30, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04536116
Responsible party
Servait Coralie (Radiology technician, Central Hospital, Nancy, France) — Principal investigator
First posted
Sep 2, 2020
Start date
Nov 4, 2020
Primary completion
Oct 18, 2023
Completion
Oct 18, 2023
Last update
Jan 30, 2025

Study contacts

Coralie SERVAIT, PI
principal investigator · CHRU de Nancy

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion